Literature DB >> 9244184

Effects of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on the growth of tumorigenic cell lines in culture.

X P Shi1, K C Yin, J Ahern, L J Davis, A M Stern, L Waxman.   

Abstract

N1-guanyl-1,7-diaminoheptane (GC7) is a potent inhibitor of deoxyhypusine synthase (DHS), the enzyme that catalyzes the first step in the hypusination of eukaryotic translation initiation factor 5A (eIF-5A). Since eIF-5A is the only known cellular substrate for DHS and GC7 has been reported to block the proliferation of CHO cells, it has been suggested that DHS may be a novel target for anti-cancer therapy. In the present study we investigated the antiproliferative effect of GC7 on several tumorigenic cell lines under various growth conditions. We found that this compound inhibits the proliferation of H9 cells in suspension culture and the growth of HeLa cells and v-src-transformed NIH3T3 cells under both anchorage-dependent and anchorage-independent conditions. Moreover, studies with NIH3T3 cells and v-src-transformed NIH3T3 cells show that GC7 inhibits the growth of both cell lines in monolayer culture with similar potency and could not reverse the transformed phenotype. In addition, the v-src-transformed cells grown under both anchorage-dependent and anchorage-independent conditions showed similar sensitivity toward GC7. These data indicate that GC7 acts as a general antiproliferative agent and does not appear to preferentially target tumorigenic cell types. Cell cycle analysis show that GC7 reduces the CHO-K1 cell population in the G1-phase of the cell cycle by 42% and increases the number of cells in the S-phase by 44%. This cell cycle distribution profile strikingly resembles the distribution of cells treated with puromycin. This result supports the hypothesis that the synthesis of a subset of proteins important for the S-phase progression of CHO-K1 cells might be dependent upon hypusinated eIF-5A. Thus the antiproliferative effect of GC7 appears to be related to its interference with the progression of cell cycle, which also provides a possible explanation for the lack of selectivity of GC7 between nontransformed and transformed cell types tested in this study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9244184     DOI: 10.1016/0167-4889(95)00165-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Cell cycle arrest in archaea by the hypusination inhibitor N(1)-guanyl-1,7-diaminoheptane.

Authors:  B P Jansson; L Malandrin; H E Johansson
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

2.  Insulin action on protein synthesis and its association with eIF5A expression and hypusination.

Authors:  André Ricardo Gomes de Proença; Karina Danielle Pereira; Leticia Meneguello; Leticia Tamborlin; Augusto Ducati Luchessi
Journal:  Mol Biol Rep       Date:  2018-12-05       Impact factor: 2.316

3.  A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.

Authors:  Ken Fujimura; Tracy Wright; Jan Strnadel; Sharmeela Kaushal; Cristina Metildi; Andrew M Lowy; Michael Bouvet; Jonathan A Kelber; Richard L Klemke
Journal:  Cancer Res       Date:  2014-09-26       Impact factor: 12.701

4.  eIF5A2 is an alternative pathway for cell proliferation in cetuximab-treated epithelial hepatocellular carcinoma.

Authors:  Fei Xue; Yanhui Liu; Haoyuan Chu; Yu Wen; Lei Yan; Qiang Tang; Erhui Xiao; Dongyi Zhang; Hongwei Zhang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

5.  Inhibition of eIF5A results in aberrant uterine natural killer cell function and embryo loss in mice.

Authors:  Xiaoli Qin; Xiaorui Liu; Bin Shan; Lijuan Shi; Surendra Sharma; Ji Wu; Yi Lin
Journal:  Am J Reprod Immunol       Date:  2014-01-02       Impact factor: 3.886

6.  KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop.

Authors:  Ken Fujimura; Huawei Wang; Felicia Watson; Richard L Klemke
Journal:  Cancer Res       Date:  2018-01-10       Impact factor: 12.701

7.  Effect of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis.

Authors:  Yoon Lee; Hyun-Kyung Kim; Hyo-Eun Park; Myung Hee Park; Young Ae Joe
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

8.  Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Abdullah Zorluoglu; Tuncay Yilmazlar; Secil Ak; Omer Yerci; Ersin Ozturk; Gorkem Umut; Turkkan Evrensel
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-16       Impact factor: 4.553

9.  eIF5A promotes translation elongation, polysome disassembly and stress granule assembly.

Authors:  Chi Ho Li; Takbum Ohn; Pavel Ivanov; Sarah Tisdale; Paul Anderson
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

10.  Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injury.

Authors:  Christopher C Moore; Edward N Martin; Grace Lee; Catherine Taylor; Richard Dondero; Leonid L Reznikov; Charles Dinarello; John Thompson; W Michael Scheld
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.